期刊文献+

对高血压和冠心病患者中风的回顾——聚焦钙通道阻滞剂 被引量:3

下载PDF
导出
摘要 脑卒中是世界上发病率和死亡率都很高的疾病之一。高血压是脑卒中最重要的危险因素,使脑卒中风险性显著升高。冠心病经常和高血压同时并存,同样预示着脑卒中风险的增加。高血压患者的血压降至达标可显著减少致死性和非致死性脑卒中的发生。有效地控制血压对于冠心病患者更为重要,因为他们有更高的脑卒中风险性。对合并有心绞痛或冠心病的脑卒中患者,降压治疗是否有效这方面的资料还很少,而且说法不一。直到今天,对冠心病患者的血压管理策略只能来源于高血压高危患者小部分的亚组资料。已有结果显示,钙通道阻滞剂优于其他抗高血压制剂。ACTION试验对钙通道阻滞剂类给冠心病合并高血压患者带来的获益做了更深入的研究。除了稳定型心绞痛最好的惯例治疗,对冠心病合并高血压的高危患者给予nifedipineGITS,可使脑卒中的风险显著降低,证明他们需要有效地控制血压。
出处 《国外医学(医学地理分册)》 CAS 2007年第3期114-116,共3页 Foreign Medical Sciences:Section of Medgeography
  • 相关文献

参考文献6

  • 1Bangalore S, Messerli FH. A review of stroke in patients with hypertension and coronary artery disease: focus on calcium channel blockers[J]. Int J Clin Pract, 2006, 60(10):1281 - 1286.
  • 2Thorn T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J]. Circulation, 2006,113 : 85 - 151.
  • 3Seshadri S, Beiser A, Kelly- Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study[J]. Stroke, 2006,37: 279-280.
  • 4Li C, Engstrom G, Hedblad B, etal. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study[J]. Stroke, 2005,36: 234- 238.
  • 5Schrader J, L? ders S, Kulschewski A, et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Principal results of a prospective randomized controlled study (MOSES)[J]. Stroke, 2005, 36:1218 - 1226.
  • 6Lubsen J, Wagener G, Kirwan BA, et al. Effect of long - acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial[J].J Hypertens, 2005, 23: 641- 648.

同被引文献11

  • 1刘瑶,李琳,严玉仙.钙在健康与疾病中的作用[J].国外医学(医学地理分册),2007,28(1):30-32. 被引量:4
  • 2Anne BN,Barbara L N,Diane G I. Coronary artery calcium,cordially,arotid artery wall thickness,and cardiovascular disease outcomes in adults 70 to 99 years old[J].American Journal of Cardiology,2008,(02):186-192.
  • 3Diehr P,Johnson LL,Patrick DL. Methods for incorporating death into health-related variables in longitudinal studies[J].Journal of Clinical Epidemiology,2005.1115-1124.
  • 4Heagerty PJ,Zheng Y. Survival model predictive accuracy and ROC curves[J].Biometrics,2005.92-105.
  • 5Pencina MJ,Dagostino RB. Overall C as a measure of discrimination in survival analysis:model specific population value and confidence interval estimation[J].Statistics in Medicine,2004.2109-2123.
  • 6Arad Y,Goodman KJ,Roth M. Coronary carcification,coronary disease risk factors,C-reactive protein,and atherosclerotic cardiovascular disease events:the St.Francis Heart Study[J].Journal of the American College of Cardiology,2005.158-165.
  • 7Greenland P,Labree L,Azen SP. Coronary artery calcium score combined with framingham score for risk prediction in asymptomatic individuals[J].Journal of the American Medical Association,2004.210-215.
  • 8袁炜,朱雯瑾,薛小临.血清离子钙与心血管疾病关系的18年随访研究[J].国外医学(医学地理分册),2008,29(3):116-117. 被引量:2
  • 9吴人照,杨兵勋,李亚平,张旭峰,杨芳亮,夏克中,陈宇,郑纯威,李端扬,戴关海,杨锋.铁皮石斛对易卒中型自发性高血压大鼠45周生存情况影响的实验研究[J].浙江中医杂志,2010,45(9):647-650. 被引量:17
  • 10吴人照,杨兵勋,李亚平,张旭峰,杨芳亮,夏克中,陈宇,郑纯威,李端扬,戴关海,杨锋.铁皮石斛对易卒中型自发性高血压大鼠(SHR-sp)36周血压影响的实验研究[J].浙江中医杂志,2010,45(10):723-725. 被引量:20

引证文献3

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部